Hongbo Deng, Ph.D.

Vice President of Medicinal Chemistry

Therapeutic Areas

Drug	Indication	Phase
GO-4305C	Metastatic cancers, including BRCA-associated pancreatic ductal adenocarcinoma	Phase 1
GO-2301	Wet age-related macular degeneration (AMD) and diabetic retinopathy	Preclinical